HomeALZN • NASDAQ
Alzamend Neuro Inc
add
$3.40
3.34%
After Hours:(0.00%)0.00
$3.40
Closed: May 16, 5:15:04 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jan 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.04M | -61.00% |
Net income | -1.04M | 60.96% |
Net profit margin | — | — |
Earnings per share | -1.71 | 95.00% |
EBITDA | -1.02M | 61.29% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jan 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.36M | 1,087.18% |
Total assets | 4.18M | 433.53% |
Total liabilities | 725.85K | -84.11% |
Total equity | 3.45M | — |
Shares outstanding | 733.06K | — |
Price to book | 0.61 | — |
Return on assets | -56.48% | — |
Return on capital | -72.01% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jan 2025info | Y/Y change |
---|---|---|
Net income | -1.04M | 60.96% |
Cash from operations | -1.42M | 29.93% |
Cash from investing | 0.00 | — |
Cash from financing | 688.70K | -67.43% |
Net change in cash | -734.94K | -987.73% |
Free cash flow | -1.00M | 3.21% |
Previous close
$3.29
Day range
$3.06 - $3.48
Year range
$3.06 - $135.54
Market cap
2.72M USD
Avg Volume
227.99K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
6